Drug Interaction Report

Lovastatin and Fenofibrate: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Fenofibrate

Antara Antara® Fenoglide Fenoglide® Fibricor Lipidil® Lipofen Lipofen®
+

Lovastatin

Altocor® Altoprev Altoprev® Mevacor®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 127 documented Lovastatin interactions, 66 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
unspecified
Evidence
probable
Severity
Major

What happens

An increased risk of myopathy or rhabdomyolysis

Interaction Deep Dive

Avoid concomitant use of fenofibrate and HMG-CoA reductase inhibitors, including lovastatin, as it may increase the risk of myopathy or rhabdomyolysis2, unless the potential benefit from further lipid level adjustments outweighs the increased risk 345. If concurrent therapy is deemed necessary, the lovastatin dose should not exceed 20 mg/day 1. Also, monitor the patient for signs and symptoms of myopathy, or rhabdomyolysis (muscle pain, tenderness, or weakness), particularly during initiation of therapy and during upward dosage titration of statin therapy 2.

Why it happens (mechanism)

Additive risk of myopathy

Literature reports

2 reports — tap to read

a) Data from observational studies indicate that the risk for rhabdomyolysis is increased when fibrates are coadministered with a statin. Coadministration of atorvastatin, 20 mg once daily for 10 days, with fenofibrate, 160 mg once daily for 10 days, reduced the AUC and Cmax of fenofibrate by 2% and 4% respectively. Whereas, coadministration of pravastatin, 40 mg as a single dose, with fenofibrate, three times 67 mg(2) as a single dose, reduced the AUC and Cmax of fenofibrate by 1% and 2% respectively. And, coadministration of fluvastatin, 40 mg as a single dose, with fenofibrate, 160 mg once single dose, reduced the AUC and Cmax of fenofibrate by 2% and 10% respectively 2.

b) Data from observational studies suggest that the risk for rhabdomyolysis is increased when fibrates, in particular gemfibrozil, are coadministered with an HMG-CoA reductase inhibitor (statin) 5.

Common questions

Can I take Lovastatin and Fenofibrate together?

An increased risk of myopathy or rhabdomyolysis Always confirm with your pharmacist or prescriber before making any change.

How serious is the Lovastatin and Fenofibrate interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Lovastatin or Fenofibrate need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (5)

  1. Product Information: MEVACOR(R) oral tablets, lovastatin oral tablets. Merck Sharp & Dohme Corp. (per FDA), Whitehouse Station, NJ, 2014. DailyMed
  2. Product Information: TRIGLIDE(R) oral tablets, fenofibrate oral tablets. Casper Pharma LLC (per FDA), East Brunswick, NJ, 2024. DailyMed
  3. Product Information: ANTARA(R) oral capsules, fenofibrate micronized oral capsules. Lupin Pharmaceuticals Inc (per FDA), Naples, FL, 2024. DailyMed
  4. Product Information: TRICOR oral tablets, fenofibrate oral tablets. AbbVie Inc (per FDA), North Chicago, IL, 2021. DailyMed
  5. Product Information: FIBRICOR(R) oral tablets, fenofibric acid oral tablets. Athena Bioscience LLC (per FDA), Athens, GA, 2021. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.